Koronis Pharmaceuticals. Report issue

For profit Phase 2
Founded: Seattle WA United States (1998)
Status: Defunct (2014)

Organization Overview

First Clinical Trial
2005
NCT00129194
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Koronis Biomedical Technologies

Active Ingredients

Drugs in Phase 2 Trials (1)

kp1461 (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

HIV Infections (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 2
  • # of Trial APIs: 1